Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $242.50. The company's market cap stands at 584.42B, with a P/E ratio of 22.38 and a dividend yield of 2.1%.
On 2026-02-21, Johnson & Johnson(JNJ) stock traded between a low of $240.28 and a high of $246.88. Shares are currently priced at $242.50, which is +0.9% above the low and -1.8% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 13.55M, against a daily average of 9.67M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $246.96 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $246.96 at its peak.
JNJ News
Looking at the universe of stocks we cover at Dividend Channel, on 2/24/26, Johnson & Johnson (Symbol: JNJ), United Fire Group, Inc. (Symbol: UFCS), and Ryan Sp...
This week's dividend activity included increased payouts from Sherwin-Williams (SHW) and Analog Devices (ADI) as well as declarations from companies such as Hal...
Johnson & Johnson (NYSE:JNJ) is reportedly preparing for a potential sale of its orthopedics unit, DePuy Synthes, as it advances plans to separate the business....
Analyst ratings
57%
of 28 ratingsMore JNJ News
If you have some spare cash, it's a great idea to put it into some dividend-paying stocks. They're a useful source of passive income that can help supplement yo...
Healthcare giant Johnson & Johnson (JNJ) is gearing up to sell its orthopedics unit, with several large buyout firms already showing interest, Bloomberg reporte...
Johnson & Johnson “announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and...
Johnson & Johnson is preparing a potential sale of its orthopedics unit DePuy Synthes, Michelle Davis, Vinicy Chan, Dinesh Nair and Ryan Gould of Bloomberg repo...
14:16 EST Johnson & Johnson preparing for sale of orthopedics unit, Bloomberg says Published first on TheFly – the ultimate source for real-time, market-moving...
Johnson & Johnson on Wednesday announced plans to invest more than $1 billion in a next-generation manufacturing facility that will produce advanced cell therap...
It looks like Johnson & Johnson ( ) is about to go ex-dividend in the next 4 days. The ex-dividend date occurs one day before the record date, which is the day...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.